Home / Products /Genome Editing /KO Cell Lines /PALS2 Knockout cell line (A549)
A549

PALS2 Knockout cell line (A549)

Catalog Number: KO05083

Price: Online Inquiry

Specifications KO Solutions KO Cell Line Workflow Handling procedures Downloads Related products

Specifications

Product Information
Product Name PALS2 Knockout cell line (A549)
specification 1*10^6
Storage and transportation Dry ice preservation/T25 live cell transportation.
Cell morphology Epithelioid, adherent cell
Passage ratio 1:3~1:4
species Human
Gene PALS2
Gene ID 51678
Build method Electric rotation method / virus method
Mycoplasma testing Negative
Cultivation system 90% F12K+10% FBS
Parental Cell Line A549
Quality Control Genotype: PALS2 Knockout cell line (A549) >95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins.
Gene Information
Gene Official Full Name protein associated with LIN7 2, MAGUK p55 family memberprovided by HGNC
Also known as MPP6; VAM1; p55T; VAM-1
Gene Description Members of the peripheral membrane-associated guanylate kinase (MAGUK) family function in tumor suppression and receptor clustering by forming multiprotein complexes containing distinct sets of transmembrane, cytoskeletal, and cytoplasmic signaling proteins. All MAGUKs contain a PDZ-SH3-GUK core and are divided into 4 subfamilies, DLG-like (see DLG1; MIM 601014), ZO1-like (see TJP1; MIM 601009), p55-like (see MPP1; MIM 305360), and LIN2-like (see CASK; MIM 300172), based on their size and the presence of additional domains. MPP6 is a member of the p55-like MAGUK subfamily (Tseng et al., 2001 [PubMed 11311936]).[supplied by OMIM, Mar 2008]
Expression Broad expression in gall bladder (RPKM 5.7), testis (RPKM 4.9) and 23 other tissues See more

KO Solutions

We develop gene knockout solutions tailored to customer requirements and the condition of the target gene.

  • Editing Tools

Cas9 Protein

Cas9 mRNA sgRNA

Cas9 Plasmid

Cas9 Virus

A – Exon KO

gRNAs are designed in the introns flanking the exon, targeting non-multiple-of-3 base deletions in the exon, resulting in frameshift mutations.

B - Frameshift KO

gRNAs are designed within the exon, creating non-multiple-of-3 base deletions to induce frameshift mutations.

C - Complete KO

The entire gene coding sequence is deleted, achieving large-scale knockout effects.

KO Cell Line Workflow

KO Strategy Design

CRISPR Plasmid/Lentiviral Vector Construction

Lentiviral Packaging

Cell Transfection/Lentiviral Infection

Drug Selection

Cell Cryopreservation

Quality Control

Sequencing Validation

Monoclonal Cell Line Generation

Pool Efficiency Validation

Handling procedures

Cell Thawing

  • Pre-warm complete culture medium in a 37°C water bath.
  • Thaw the cryovial in a 37°C water bath for 1–2 minutes.
  • Transfer the cryovial to a biosafety cabinet (BSC) and wipe the surface with 70% ethanol.
  • Loosen the cap and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete medium.
  • Centrifuge at 125 × g for 5–7 min at room temperature (RT), then discard the supernatant.
  • Resuspend the cell pellet in 5 mL of complete medium and transfer the suspension into a T25 flask.
  • Incubate the cells at 37°C in a 5% CO₂ incubator.
  • Recommended subculturing ratio: 1:2 to 1:3, reaching confluency in 2–3 days.

Cell Passaging

  • When cell confluence reaches 80–90%, proceed with passaging.
  • Pre-warm complete medium, PBS, and trypsin (0.25% Trypsin-EDTA, Gibco 25200-056) in a 37°C water bath. Once near 37°C, spray the bottles with 75% ethanol and place them in the BSC.
  • Retrieve the culture flask from the incubator, spray with 75% ethanol, and transfer it to the BSC.
  • To avoid dislodging cells, gently rinse the monolayer with PBS along the upper wall of the flask. Discard the PBS after washing (use 2 mL for T25 flasks).
  • Add an appropriate volume of trypsin (1.5 mL for T75, 0.5 mL for T25) and gently tilt the flask to ensure full coverage. Adjust the volume as needed. After 1–2 min, when most cells detach, neutralize digestion by adding an equal volume of complete medium. Gently pipette with a 5 mL serological pipette to ensure complete detachment.
  • Transfer the cell suspension to a 15 mL centrifuge tube and spin at 300 × g for 5 min. Discard the supernatant.
  • Resuspend the pellet in 5 mL of complete medium, adjust the seeding ratio as required, and replenish the flask with fresh medium (13–15 mL for T75, 5 mL for T25). Add 1% penicillin-streptomycin (dual antibiotic).
  • Tighten the cap, gently swirl to mix, and place the flask in a 37°C, 5% CO₂ incubator.

Cell Cryopreservation

  • Prepare cryopreservation medium in advance and pre-chill.
  • Ensure cells meet freezing criteria: healthy morphology, late-log phase growth, and absence of contamination or senescence (verify under a microscope).
  • Digest and centrifuge the cells (refer to the passaging protocol).
  • Resuspend the cell pellet in cryopreservation medium (1 mL per vial), mix thoroughly, and aliquot into cryovials.
  • Place the vials in a freezing container and store at −80°C overnight.
  • For long-term storage, transfer the cryovials to a liquid nitrogen tank.

Downloads

Please note that all services are for research use only. Not intended for any clinical use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.